| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2011 | CN101933914A Desloratadine patch and preparation method thereof |
| 01/05/2011 | CN101933913A Dexmethylphenidate hydrochloride dual-release preparation and preparation method thereof |
| 01/05/2011 | CN101933912A Preparation technology of tryptanthrin sustained-release capsule and application thereof |
| 01/05/2011 | CN101933911A Soft capsule composition for treating senile dementia and preparation method thereof |
| 01/05/2011 | CN101933910A Mecobalamin soft capsule and preparation method thereof |
| 01/05/2011 | CN101933908A Preparation process of tryptanthrin sustained release tablets and application thereof |
| 01/05/2011 | CN101933904A Vinorelbine long circulation liposome preparation and preparation method thereof |
| 01/05/2011 | CN101933902A Granisetron hydrochloride microemulsion-based gel and preparation method thereof |
| 01/05/2011 | CN101933901A Mixed suspension injection liquid containing tylosin and preparation method thereof |
| 01/05/2011 | CN101933900A Compound preparation for preventing and treating poultry liver diseases and preparation method thereof |
| 01/05/2011 | CN101933899A Edaravone injection and preparation method thereof |
| 01/05/2011 | CN101933898A New pyritinol hydrochloride injection |
| 01/05/2011 | CN101933895A Fenticonazole nitrate vaginal suppository composition |
| 01/05/2011 | CN101933894A Protecting colloid for gastroenteric mucosa |
| 01/05/2011 | CN101933863A Traditional Chinese medicine thin layer matter sanitary protecting cushion for treating pruritus vulvae |
| 01/05/2011 | CN101933744A Chinese medicinal neck pillow for treating cervical spondylosis |
| 01/05/2011 | CN101933561A Parasite expelling sausage |
| 01/05/2011 | CN101933521A Preparation and application thereof of sterilization composition |
| 01/05/2011 | CN101933513A Compound washing-free disinfection composition and preparation method thereof |
| 01/05/2011 | CN101933512A Disinfectant capable of being used with high dilution multiples, preparation method and application |
| 01/05/2011 | CN101933508A Preparation method of cyclodextrin clathrate abamectin solution |
| 01/05/2011 | CN101623271B Compound alpha-keto acid dispersible tablet |
| 01/05/2011 | CN101606922B Glucosamine potassium sulfate microcapsule and preparation method and application thereof |
| 01/05/2011 | CN101584682B Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof |
| 01/05/2011 | CN101584676B Matrine sustained release preparation and preparing method thereof |
| 01/05/2011 | CN101570516B Method for preparing 4-(3-chlorine-4-fluorophenylalanine)-7-methoxy-6-[3-(4-morpholinyl) propoxy] quinazoline |
| 01/05/2011 | CN101565426B Aspoxicillin-ethanol adduct crystalline and preparation method thereof |
| 01/05/2011 | CN101548971B Application of lignin flavanonol in preparation of antiviral drugs |
| 01/05/2011 | CN101507819B Large-grainsize medicine intercalated hydrotalcite and preparation method thereof |
| 01/05/2011 | CN101502524B Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 01/05/2011 | CN101502523B Application of benzoyl fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 01/05/2011 | CN101485681B Medicament for treating burn and scald, and preparation method thereof |
| 01/05/2011 | CN101485649B Application of Cajanus cajan stilbene acid and pinostrobin in Cajanus cajan leaf in preparing anti-herpesvirus medicament |
| 01/05/2011 | CN101429154B Anhydrous alvimopan and medicament composition thereof |
| 01/05/2011 | CN101422555B Formulation capable of defaecating, adjusting qi and blood, improving internal secretion and preventing senescence and preparation method |
| 01/05/2011 | CN101390858B Uses of loperamide hydrochloride in preparing antineoplastic medicine |
| 01/05/2011 | CN101374511B Pharmaceutical formulations of gallium salts |
| 01/05/2011 | CN101357153B No-scar medicine for treating burn and scald and preparation method thereof |
| 01/05/2011 | CN101342174B Phthiobuzonum/diclothane compound topical formulation |
| 01/05/2011 | CN101322722B Compound carbamylcholine chloride injection for animals and preparation method thereof |
| 01/05/2011 | CN101297954B Unbilical medicament for treating cough and preparation thereof |
| 01/05/2011 | CN101284040B Complex immunity strengthening agent for crabeater young fish |
| 01/05/2011 | CN101269060B Use of compound HSR01-4-9 in preparing multi-drug resistant aureus restrainer |
| 01/05/2011 | CN101250185B Pyrrone nidazole ester compound as well as preparation method and use thereof |
| 01/05/2011 | CN101224226B Novel clinical uses of big nilgiri nettle |
| 01/05/2011 | CN101208085B Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| 01/05/2011 | CN101198377B Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient |
| 01/05/2011 | CN101195646B Production method of stilbene glycoside extract |
| 01/05/2011 | CN101185625B Rubitecan sustained-release implant for treating solid tumor |
| 01/05/2011 | CN101181234B Literdinun sustained-release implantation agent for curing entity tumour |
| 01/05/2011 | CN101177415B Method for preparing new crystal form of anti-cancer compound ZD1839 |
| 01/05/2011 | CN101089000B Spiro piperazine quaternary ammonium salt compound and its preparation method and application |
| 01/05/2011 | CN101066253B Slow releasing ranolazine tablet |
| 01/05/2011 | CN101052404B Insecticide composition |
| 01/05/2011 | CN101020059B Medicine composition containing docetaxel matter and its preparation process |
| 01/05/2011 | CN101014334B Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients |
| 01/05/2011 | CN101002832B Granulated quickly dissolving medicine for relaxing bowel |
| 01/04/2011 | US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/04/2011 | US7863464 Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 01/04/2011 | US7863450 e.g. 1-{3-[4-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)phenoxy]propyl}piperidine; histamine H3 receptor antagonist; anxiolytic agent, antidepressant, cognition activator; neurodegenerative diseases, eating disorder, attention deficit disorder, Alzheimer's, Parkinson's diseases, schizophrenia |
| 01/04/2011 | US7863449 Modulators of muscarinic receptors |
| 01/04/2011 | US7863446 Heterocycles |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863444 Antiproliferative agents; anticancer agents; antiarthritic agents; antiinflamamtory agents |
| 01/04/2011 | US7863435 Nucleotide sequences coding transport protein; increasing fermentation concentration of threonine in grampositive bacteria |
| 01/04/2011 | US7863337 anticarcinogenic drug preparation; into tablets, capsules, pills, sustained-released formulation, injectable solution and powder; dissolve the drug in peanut oil, and adding starch and cyclodextrin for granulating, mixing and drying; treating cancer of liver, intestines, and lung |
| 01/04/2011 | US7863336 stable liquid drug composition comprising carbidopa, and arginine for treating Parkinson's disease; additional including entacapone or tolcapone; long half life; transdermal delivery |
| 01/04/2011 | US7863335 Non-antibiotic intervention of chlamydial infection |
| 01/04/2011 | US7863334 Guanylhydrazone compounds, compositions, methods of making and using |
| 01/04/2011 | US7863333 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide |
| 01/04/2011 | US7863332 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics |
| 01/04/2011 | US7863331 micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant that improves bioavailability; reducing food effect when treating hyperlipemias; FDA Orange book listed patent for fenofibrate |
| 01/04/2011 | US7863330 Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders |
| 01/04/2011 | US7863329 3-{4-[1-(4'-tert-Butyl-biphenyl-4-ylmethyl)-3-methyl-butyl]-benzoylamino}-propionic acid, used as hypoglycemic agents of for the treatment of metabolic disorders such as diabetes |
| 01/04/2011 | US7863328 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 01/04/2011 | US7863327 Chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel disease, and multiple sclerosis |
| 01/04/2011 | US7863326 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superinfections and fungal recurrences |
| 01/04/2011 | US7863325 used for the treatment of cancer, chronic inflammation, infection, cystic fibrosis, amyloidosis and infection; administering sodium salt of 4',5,7-trihydroxyisoflavone-5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
| 01/04/2011 | US7863324 inhibiting the growth, delaying the progression or preventing the recurrence of androgen-independent prostate cancer tumor cells in a human comprising administering 2,2,5,7,8-pentamethyl-6-chromanol; anticarcinogenic agents |
| 01/04/2011 | US7863323 such as 4-[[2-(3,4-dihydroxyphenyl)-3-hydroxy-4-oxochromen-6-yl]amino]-4-oxobutanoic acid, useful in the treatment of conditions that require an antioxidant effect such as cardiovascular disease, without eliciting a vasodilatory effect |
| 01/04/2011 | US7863322 Anti-cancer combinations |
| 01/04/2011 | US7863321 Anti-cancer combinations |
| 01/04/2011 | US7863320 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
| 01/04/2011 | US7863319 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/04/2011 | US7863318 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 01/04/2011 | US7863316 tablet comprising water dispersible rate controlling polymer hydroxypropyl methylcellulose, and polyvinyl pyrrolidone; effective plasma levels over 24 hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients |
| 01/04/2011 | US7863315 enzyme inhibitors such as 2-(5-(((5-fluoro-2-oxoindolin-3- ylidene)hydrazono)methyl)-2,4-di- methyl-1H-pyrrole-3-carboxamido)- N-hydroxyacetamide, used for treating , fragile X syndrome, leukemia, cancer, cardiac hypertrophy, bone, immunological, nervous system, neurodegenerative and genetic disorders |
| 01/04/2011 | US7863313 Methods for the treatment of inflammatory diseases |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7863311 administering sublingually to a horse a semisolid transmucosal gel containing detomidine, hydroxypropyl cellulose, sodium lauryl sulfate, propylene glycol and water for providing sedation and analgesia; rapid onset of action, low irritation potential in the oral mucosa |
| 01/04/2011 | US7863310 Kinase inhibitors |
| 01/04/2011 | US7863309 Dual-acting antihypertensive agents |
| 01/04/2011 | US7863308 Substituted thiophenes |
| 01/04/2011 | US7863307 Process for synthesizing a CETP inhibitor |
| 01/04/2011 | US7863306 Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 01/04/2011 | US7863305 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
| 01/04/2011 | US7863304 Which protect neural cells from degeneration and/or death in response to injury or disease; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease |
| 01/04/2011 | US7863302 Compounds and methods for modulating FX-receptors |
| 01/04/2011 | US7863301 Increasing glucose-induced insulin secretion from pancreatic beta cells in individuals having hyperglycemia, by administering a pyridine dicarboxylates, inhibitor of prolyl-4-hydroxylase; Type II diabetes |
| 01/04/2011 | US7863300 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione |